Read our new publication

Identification and antifungal susceptibility patterns of reference yeast strains to novel and conventional agents: a comparative study using CLSI, EUCAST and Sensititre YeastOne methods

Evolution of the governance

See all our latest press releases Mr. Alexandre Moulin, previously Deputy Managing Director of BIOASTER, is appointed Managing Director of BIOASTER. Mr. Christophe Védrine, previously Director of Technologies at BIOASTER,...

New publication in Nature communications

Publication alert: Our colleague Dr. Magali Sarafian has just published in Nature Communications, as co-first author. In this work, they demonstrated a robust daily rhythm in the overall circulating bile...

New collaboration!

BIOASTER collaborates with ZYNNON to advance VOC-based detection and identification of pathogens in clinical and industrial microbiology settings   BIOASTER – Lyon, France, ZYNNON AG – Schindellegi, Switzerland, September 26,...

New sequencer @BIOASTER

BIOASTER is pleased to announce the recent acquisition of the newest GridION, a sequencer of third generation entirely developed by Oxford Nanopore Technologies. This installation is the logical consequence of...